Navigation Links
CryoLife Reports Record Quarterly Revenues of $28.2 Million
Date:10/29/2009

2010 Financial Guidance

The Company plans to issue its initial 2010 financial guidance on either December 1 or 2, 2009 in connection with its presentation at the Piper Jaffray Healthcare Conference in New York.

Webcast and Conference Call Information

The Company will hold a teleconference call and live webcast today at 10:00 a.m. Eastern Time to discuss the results followed by a question and answer session hosted by Mr. Anderson.

To listen to the live teleconference, please dial 201-689-8261 a few minutes prior to 10:00 a.m. A replay of the teleconference will be available from October 29 through November 5 and can be accessed by calling 877-660-6853 (toll free) or 201-612-7415. The account number for the replay is 244 and the conference number is 333891.

The live webcast and replay can be accessed by going to the Investor Relations section of the CryoLife Web site at www.cryolife.com and selecting the heading Webcasts & Presentations.

About CryoLife, Inc.

Founded in 1984, CryoLife, Inc. is a leader in the processing and distribution of implantable living human tissues for use in cardiac and vascular surgeries throughout the U.S. and Canada. The Company's CryoValve® SG pulmonary heart valve, processed using CryoLife's proprietary SynerGraft® technology, has FDA 510(k) clearance for the replacement of diseased, damaged, malformed, or malfunctioning native or prosthetic pulmonary valves. The Company's CryoPatch® SG pulmonary cardiac patch has FDA 510(k) clearance for the repair or reconstruction of the right ventricular outflow tract (RVOT), which is a surgery commonly performed in children with congenital heart defects, such as Tetralogy of Fallot, Truncus Arteriosus, and Pulmonary Atresia. CryoPatch SG is distributed in three anatomic configurations: pulmonary hemi-artery, pulmonary trunk, an
'/>"/>

SOURCE CryoLife, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. CryoLife Receives FDA Approval to Begin U.S. Clinical Trial for BioFoam(R)
2. CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic
3. Endo Pharmaceuticals Reports Third Quarter 2009 Financial Results and Increases Full-Year Financial Guidance
4. Cepheid Reports 2009 Third Quarter Results
5. Neurocrine Biosciences Reports Third Quarter 2009 Results
6. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
7. Endologix Reports 47% Third Quarter 2009 Revenue Growth
8. PAREXEL Reports First Quarter Fiscal Year 2010 Financial Results
9. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010
10. NxStage(R) Reports Significant Interim FREEDOM Study Results
11. Hospira Reports Third-Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... NEW YORK and ...  CMC Biologics, a global leader in clinical ... Development Corporation (River Vision), a private company focused ... into an agreement for the process transfer and ... monoclonal antibody targeting insulin-like growth factor 1 that ...
(Date:7/28/2015)...  Insulet Corporation (NASDAQ: PODD ), the leader ... Insulin Management System, today announced that Dr. ... of Directors. Dr. Hopfield brings more than ... Board. She currently serves as the Vice Chair of ... largest diabetes research center, diabetes clinic, and provider of ...
(Date:7/28/2015)... 2015  Express Scripts Holding Company (Nasdaq: ESRX ... Express Scripts stockholders of $600.1 million, or $0.88 per ... in Table 4, were $1.44 for the second quarter. ... companies across healthcare are validating the need for size ... Officer. "But, what matters most is how that size ...
Breaking Medicine Technology:CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy 2CMC Biologics and River Vision Development Corporation Announce Manufacturing Agreement for RV001, a Monoclonal Antibody to Treat Grave's Orbitopathy 3Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 2Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 3Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 4Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 5Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 6Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 7Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 8Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 9Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 10Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 11Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 12Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 13Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 14Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 15Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 16Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 17Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 18Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 19Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 20Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 21Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 22Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 23Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 24Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range 25
(Date:7/29/2015)... ... ... People that are passionate about gardening and those that have never planted ... and enhanced mineral product for growing ideal crops. , The Garden Tower ... rooftop – can hold up to 100 plants in just 4 square feet of ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... board-certified gastroenterologist, has launched a chewable version of its EndoMune Jr. probiotic supplement ... a tasty, all-natural supplement that children can enjoy to maintain a healthy balance ...
(Date:7/29/2015)... County, CA (PRWEB) , ... July 29, 2015 , ... ... mouthwashes in a variety of gourmet flavors. , Nature’s Artisan was founded by Tina ... the Post-Baccalaureate program at the UCLA School of Dentistry. Tina was amazed when she ...
(Date:7/28/2015)... (PRWEB) , ... July 29, 2015 , ... City Sports, ... enthusiasts, today announced veteran retail executive Marty Hanaka as CEO. , Hanaka, who has ... last year as an operating partner at the Highland Consumer Fund has had previous ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ProFont is ... Cut Pro X . With ProFont: Cursive users can generate a hand drawn feel ... customizable leaving endless stylization. Users can select from either the upper and lowercase alphabet, ...
Breaking Medicine News(10 mins):Health News:Mercola.com Introduces NEW Garden Tower and Enhanced Mineral Solution for Healthy Plants 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 2Health News:EndoMune Advanced Probiotic adds Chewable Tablet for Kids to Product Line 3Health News:Discover a New Take on Oral Care with Nature’s Artisan Gourmet Mouthwashes 2Health News:City Sports Names Marty Hanaka CEO 2Health News:Announcing ProFont Cursive from FCPX Effects developer Pixel Film Studios 2
... of younger minority adults receiving medical care in settings that ... healthcare safety net). Poor, minority adults with moderate to severe ... progress to kidney failure than non-Hispanic whites. These are the ... Journal of the American Society of Nephrology (CJASN). ...
... only a third of those who get invasive procedure have vessel ... into an emergency room complaining of chest pains, the odds are ... thin wire is snaked into your heart to determine whether a ... do have the invasive procedure, the odds are even higher -- ...
... remain, experts say, , WEDNESDAY, March 10 (HealthDay News) -- ... have a vaginal delivery later, an expert panel concluded Wednesday. ... experts, but the panel said that just because a woman ... she must have one in subsequent deliveries. , However, current ...
... United today announce that the Florida Hospital Patient Protection Act of 2010 has been filed in the state legislature by authors Rep. Oscar Braynon and Sen. Tony ... ... ... ...
... by ultrasound guidance, treating tumors with extreme heat or ... to early research presented at the second AACR Dead ... the Laboratory to the Clinic, held March 7-10, 2010. ... treatments are beneficial in curing both malignant and benign ...
... Today RetireSafe, representing 400,000 senior citizen supporters across America, urged seniors nationwide to call on Congress to save high-quality ... ration high-quality physician hospital care to Medicare patients, as a "cost savings." , ... ... , ...
Cached Medicine News:Health News:Study: Kidney disease a big risk for younger, low-income minorities 2Health News:Doctors Turning to Cardiac Catheterization Too Quickly 2Health News:Doctors Turning to Cardiac Catheterization Too Quickly 3Health News:Panel Finds Many Women Can Avoid Repeat C-Sections 2Health News:Panel Finds Many Women Can Avoid Repeat C-Sections 3Health News:Lifesaving Bills Filed in Florida Legislature to Guarantee Patient Safety Improvements 2Health News:Lifesaving Bills Filed in Florida Legislature to Guarantee Patient Safety Improvements 3Health News:RetireSafe Urges All Seniors to Call on Congress to Save Physician Hospitals' Quality Care for Medicare Patients 2Health News:RetireSafe Urges All Seniors to Call on Congress to Save Physician Hospitals' Quality Care for Medicare Patients 3
... The SmartCycler System is a rapid, real-time ... prepared biological samples. By automating much of ... site individually programmable, it is the fastest, ... now on the market. The SmartCycler delivers ...
... easily converts any DNA Engine thermal cycler into ... with any of our user-changeable sample blocks. The ... it to keep pace with the evolving needs ... DNA Engine base units, new or existing. The ...
Mx3000P instrument, notebook computer, Mx3000P software package, user's manual, one Brilliant QPCR Reagent of your choice, and custom filter wheel with 4 filters chosen from: FAM/SYBR Green I, TET, H...
... Sequence Detection System is a complete, ... quantitates nucleic acid sequences. In real-time ... product is made possible by combining ... software in a single instrument. Quantitative ...
Medicine Products: